Origins of central mucoepidermoid carcinoma: systematic review by Kansou, Khalil Abdo et al.




Origins of central mucoepidermoid carcinoma: systematic review 
Origens do carcinoma mucoepidermoide central: revisão sistemática
Khalil Abdo Kansou1, Mozarth Matheus Silvino do Nascimento2, Elaine Rossi Ribeiro 3 
Kansou KA, Nascimento MMS, Ribeiro ER. Origins of central mucoepidermoid carcinoma: systematic review / Origens do carcinoma 
mucoepidermoide central: revisão sistemática. Rev Med (São Paulo). 2021 Jan-Feb;100(1):41-8.
1. Faculdades Pequeno Príncipe, Acadêmicos Curso de Medicina. ORCID: Kansou KA - https://orcid.org/ 0000-0002-4847-0437; 
Nascimento MMS - https://orcid.org/ 0000-0002-2654-7456. E-mail: khalilabdo8@gmail.com, mozarthnascimento@gmail.com.
2. Faculdades Pequeno Príncipe, Pesquisadora docente Programa Ensino nas Ciências da Saúde e Curso de Medicina. ORCID: https://
orcid.org/ 0000-0003-3492-217X. E-mail: elaine.rossi@hotmail.com.
Endereço para correspondência: Elaine Rossi Ribeiro. Rua Carneiro Lobo, 333. Curitiba, PR.
ABSTRACT: Mucoepidermoid carcinoma is a malignant 
tumor usually associated with salivary glands. Only 2-4% of 
all mucoepidermoid carcinomas have a primary intraosseous 
site (central mucoepidermoid carcinoma), which the etiogenesis 
remaining obscure, justifying the importance of researching 
the subject. Objective: Discover the most probable etiology 
(or etiologies) of intraosseous mucoepidermoid carcinoma. 
Method: systematic review according to the recommendations 
of PRISMA (Preferred Reporting items for Systematics Review 
and Meta-analysis Statement). The search bases consulted were: 
PubMed, Portal CAPES and Google academic, and after the 
inclusion and exclusion criteria, seven articles were selected to 
answer the research objective, for which the Newcastle-Ottawa 
tool was applied for risk analysis of bias and methodological 
quality. The search, selection, extraction and risk of bias were 
carried out by three independent researchers. Results: There are 
two main etiological hypotheses of intraosseous mucoepidermoid 
carcinoma: (1) derived from an odontogenic cyst and (2) derived 
from ectopic remains. Conclusions: As the evidence indicates, the 
pluripotent potential of cells contained in odontogenic cysts would 
be responsible for metaplasia and subsequent carcinogenesis. In 
cases derived from ectopic remains, the association with t (11; 
19) translocation and the CTRC1-MAML2 fusion transcript as 
an etiological or early event is clear.
Keywords: Carcinoma; Etiology; Salivary glands; Submandibular 
gland.
RESUMO: O carcinoma mucoepidermoide é um tumor maligno 
geralmente associado a glândulas salivares. Apenas de 2-4% 
de todos os carcinomas mucoepidermoides apresentam sítio 
primário intraósseo (carcinoma mucoepidermoide central), 
cuja etiogenia permanece obscura, justificando a importância 
de se pesquisar o assunto. Objetivo: Conhecer a(s) etiologia(s) 
mais provável(is) do carcinoma mucoepidermoide intraósseo. 
Método: revisão sistemática de acordo com as recomendações 
do PRISMA (Preferred Reporting itens for Systemstic Review 
and Meta-analysis Statement). As bases de dados consultadas 
foram: PubMed, Portal CAPES e Google acadêmico, e após 
aplicação dos  critérios de inclusão e exclusão foram selecionados 
sete artigos que atenderam o objetivo da pesquisa, para os quais 
aplicaram-se a ferramenta Newcastle-Ottawa para análise de risco 
de viés e qualidade metodológica. A busca, seleção, extração e 
risco de viés foram feitas por três pesquisadores independentes 
Resultados: São duas as principais hipóteses etiológicas do 
carcinoma mucoepidermoide intraósseo: (1) derivado de um cisto 
odontogênico e (2) derivado de restos ectópicos. Conclusões: 
Ao que as evidências indicam o potencial pluripotente de células 
contidas nos cistos odontogênicos seria o responsável pela 
metaplasia e posterior carcinogênese. Nos casos derivados de 
restos ectópicos é clara a associação com a translocação t(11;19) 
e o transcrito de fusão CTRC1-MAML2 como um evento precoce 
ou etiológico.
Palavras-chave: Carcinoma; Etiologia; Glândulas salivares; 
Glândula submandibular.
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INTRODUCTION
Mucoepidermoid carcinoma is a malignant tumor usually associated with the salivary 
glands. It corresponds to 5%-10% of all tumors, affecting 
mainly the parotids (89.6%), the submandibular (8.4%), 
and the sublingual (0.4%) glands1. Its appearance with a 
primary bone site is much rarer, representing only 2%-4% 
of all mucoepidermoid carcinomas2.
Its intraosseous origin, although widely discussed, 
is not well understood. Four possible theories for its 
origin are suggested: 1) entrapment of the retromolar 
glands in the mandible, with subsequent neoplastic 
transformation; 2) embryonic remnants of the development 
of the submandibular gland entrapped in the mandible; 
3) neoplastic transformation of mucosecretory cells 
commonly found in the pluripotential epithelial lining of 
dentigerous cysts associated with impacted third molars; 
and 4) neoplastic transformation and invasion of the 
maxillary sinus lining3.
The first case of an intraosseous (central) 
mucoepidermoid carcinoma was described by Lepp, in 
1939, in the jaw of a 66-year-old patient3. Until 2003, less 
than 200 cases had been described so far, proving that such 
a finding is really rare4.
In a paper published in January 2018, 36 publications 
containing reports of 147 central mucoepidermoid 
carcinomas were analyzed, reaching the following results: 
it affects slightly more women than men (51.7 and 48.3% 
respectively), mainly the mandible (63.3%) rather than 
the jaw (36.7%); it has a predilection for people aged ≥ 
40 years (65.3%), and the treatment of choice was radical 
surgery alone (42.9%)5.
Mucoepidermoid carcinoma affects 2.8%–15% of 
salivary cancers, therefore being the most common type at 
this site6. However, this neoplasm in a primary intraosseous 
site is much rarer, corresponding to 2%-4.3% of cases7. In 
addition, there is evidence of a predilection for the mandible 
(especially the posterior part) rather than the maxilla8. It 
mainly affects the age group of 40–50 years and twice as 
much women9,10.
Authors state that currently there are only hypotheses 
requiring confirmation, such as entrapment of the salivary 
glands within the mandible; embryonic remnants of the 
submandibular gland within the mandible; neoplastic 
transformation of mucus-secreting cells of dentigerous 
cysts, and neoplastic alteration and subsequent invasion 
of the epithelial lining of the maxillary sinus8,11.
Of these four hypotheses, the most prevalent 
(approximately 50% of the cases studied) is neoplastic 
transformation of mucus-secreting cells of dentigerous 
cysts11. The dentigerous cyst, by definition, is formed from 
odontogenic cells present in the crown of an unerupted 
tooth. It has, in its internal constitution, a cystic fluid and, 
in its external part, loose connective tissue associated with 
flat or cubic non-keratinized epithelial cells, making up 
three layers12.
Another odontogenic cyst, although much less 
prevalent, is the glandular odontogenic cyst (GOC). This 
cyst has histological and radiological characteristics that 
are very similar to the intraosseous mucoepidermoid 
carcinoma, leading some authors to believe in a possible 
relationship between them13.
However, some authors are opposed to this theory, 
claiming that the transition from a glandular odontogenic 
cyst to an intraosseous mucoepidermoid carcinoma is 
impossible14.
In tomographic images, it is similar to the 
odontogenic cyst and the glandular odontoid cyst, 
presenting a uni- or multilocular radiolucency, which makes 
the differentiation difficult with this type of image15.
At biopsy, keratinized stratified squamous epithelial 
lining can be found in the cystic lesion and, mainly, foci 
of mucous, epidermoid, and intermediate cells in fibrous 
stroma, which are characteristic of this neoplasm9.
Brookstone and Huvos Staging is used to stage and 
define treatment and prognosis: “stage 1: intact cortical 
plate + no evidence of bone expansion; stage 2: intact 
cortical bone + evidence of bone expansion; stage 3: 
cortical perforation, rupture of the underlying periosteum 
or nodal growth16”.
The treatment is divided into conservative (curettage, 
enucleation, marsupialization, local excision) or radical 
(segmental resection with or without adjacent therapy) 
methods, with the latter showing the best prognoses17.
This neoplasm is generally classified as low 
grade and has a favorable prognosis; however, if it is on 
a maxillary site, the prognosis is a little more guarded18.
Due to the difficulty in obtaining specific literature, 
the following research question was defined: What 
is (are) the most likely etiology (ies) of intraosseous 
mucoepidermoid carcinoma - IMEC? To seek the answer, 
the following objective was determined: To know the most 
probable etiology (ies) of intraosseous mucoepidermoid 
carcinoma.
METHOD
The method of choice for conducting this work was 
a systematic review, according to the recommendations 
of PRISMA (Preferred Reporting Items for Systematic 
Review and Meta-analysis Statement)19.
This review was registered on the PROSPERO 
platform on August 3, 2019, with the identification number 
CRD42020145754.
The development of the guiding question used the 
acronym PVO20 (an adaptation of PICO), with P standing 
for participants: Mucoepidermoid carcinoma with primary 
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intraosseous site; V, variables: Possible origins of IMEC; 
and O, outcomes or results: origins of IMEC.
The articles were selected from the following 
databases: PUBMED, CAPES Portal de Periódicos, and 
Google Scholar. The descriptors used, right after searching 
MeSH, were: ((“intraosseous mucoepidermoid carcinoma” 
OR “central mucoepidermoid carcinoma”) AND (precursor 
OR origin OR development OR etiology OR pathogenesis)) 
NOT report, as shown in Table 1, from May 1 to 15, 2019.
The inclusion criteria established were: being 
published in the last decade (except in PubMed, which 
was in the last 15 years); being written in Portuguese, 
English or Spanish; providing the full article for free; being 
available in full. The exclusion criteria were: editorials; 
opinion texts; journal columns; experience reports; works 
that have not been approved by the Research Ethics 
Committee, considering the rule for obtaining articles with 
high scientific evidence.
Table 1: Article search strategies
Database Descriptors Filters No
PubMed
((“intraosseous mucoepidermoid carcinoma” OR “central 
mucoepidermoid carcinoma”) AND (precursor OR origin OR 
development OR etiology OR pathogenesis)) NOT report 
# 1 Last 15 years
# 2 Article in Portuguese, English and 
Spanish




((“intraosseous mucoepidermoid carcinoma” OR “central 
mucoepidermoid carcinoma”) AND (precursor OR origin OR 
development OR etiology OR pathogenesis)) 
# 1 Last 10 years
# 2 Article in Portuguese, English and 
Spanish
# 3 Free full article
# 4 Be available for reading
8
Google Scholar
((“intraosseous mucoepidermoid carcinoma” OR “central 
mucoepidermoid carcinoma”) AND (precursor OR origin OR 
development OR etiology OR pathogenesis)) NOT report
# 1 Last 10 years
# 2 Article in Portuguese, English and 
Spanish
# 3 Free full article
51
Source: Authors, 2019.
This search resulted in 66 articles, from the three 
databases together. Then, a review was carried out by 
three independent researchers, initially for the exclusion of 
repeated articles. Next, an analysis of the title and abstract 
was performed. At this stage, some more exclusions were 
made, considering that a large number of articles that did 
not meet the inclusion criteria (n = 44) was found. Finally, 
all articles were analyzed in full by independent evaluators, 
to achieve the objective of this study (Figure 1).
In order to highlight the quality of the articles 
selected, three independent researchers used the tool 
Newcastle-Ottawa Scale21 to analyze the methodological 
quality of the articles. This tool establishes three main 
domains for the analysis of the studies: Selection, 
Comparability, and Outcome, totaling nine points, allowing 
the demonstration of strong evidence in four articles, 
moderate evidence in three of them, which is explained 
in Table 2.
Figure 1: Flowchart of article selection
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Table 2: Analysis of risk of bias according to Newcastle–Ottawa scale
ID Design Selection Comparability Outcome Total
1 Experimental with 11 cases 3 2 3 8
2 Analysis of 25 records of patients with intraosseous mucoepidermoid carcinoma treated between 1998 and 2013. 2 1 2 5
3 Experimental with 10 cases 1 2 2 5
4 Experimental with 21 cases 2 2 3 7
5 Comparative experimental with 39 cases. 2 3 3 8
6 Experimental with three cases including one case with history of primary retromolar MEC. 1 1 2 4
7 Experimental with 85 cases. 2 3 3 8
Strong evidence - 6/9; moderate evidence - 4-5 / 9; Limited evidence - <4.
Source: author, 2019.
  The extracted data were placed in a specific 
spreadsheet, highlighting author, title, journal, year and 
country of publication, objectives, methods, participants, 
and results. The characteristics selected for the analysis 
were: the methodology used in the studies (e.g., fluorescence 
in situ hybridization, real-time polymerase chain reaction, 
staining with hematoxylin eosin, or pathological analysis); 
the number of samples obtained for each study (must be at 
least three); the age and sex of each patient in the samples; 
verification of diagnostic accuracy, and the number of 
patients who relapsed.
PRESENTATION OF RESULTS
Following the application of the inclusion and 
exclusion criteria, seven articles that met the research 
objective were selected. The list of articles with general 
data is shown below, in Table 3, for better visualization.
Table 3: List of articles with general data
ID Title Authors Journal Year Country Result
1
Assessment of biologically aggressive, 
recurrent glandular odontogenic cysts 
for mastermind-like 2 (MAML2) 
rearrangements: histopathologic and 
fluorescent in situ hybridization (FISH) 
findings in 11 cases 
Greer RO, et al.14 J Oral Pathol Med 2017 USA 
One  COG case  ou t  o f  11 
d e m o n s t r a t e d  M A M L 2 
rearrangements by FISH.
2
Primary intraosseous mucoepidermoid 
carcinoma of the jaw: reappraisal of the 
MD Anderson Cancer Center experience
Bell D, et al.22 W i l e y  O n l i n e Library 2015 USA
The CRTC1-MAML2 fusion 
transcript was manifested in 9 of 
18 cases of IMEC (intraosseous 
mucoepidermoid carcinoma)
3
Fluorescence in-situ hybridization 
identifies Mastermind-like 2 (MAML2) 
rearrangement in odontogenic cysts with 
mucous prosoplasia: a pilot study
Argyris PP, et al.23 Histopathology 2014 USA All three IMECs demonstrated MAML2 rearrangement.
4
Glandular Odontogenic Cysts (GOCs) 
Lack MAML2 rearrangements: a finding 
to discredit the putative nature of GOC as 
a precursor to central mucoepidermoid 
carcinoma
Bishop JA, et al.24
Springer Science 
e Business Media 
New York
2014 USA
The MAML2 rearrangement was 
identified in all 5 of the IMEC 
group, but in none of the 21 GOC.
5
C e n t r a l  m u c o e p i d e r m o i d 
carcinoma: a clinicopathologic and 
immunohistochemical study of 39 
Chinese patients
Zhou CX, et al.18 Am J Surg Pathol 2012 China
Of the 11 cases with GOC, 8 had 
typical IMEC histology
6
CRTC1/MAML2 fusion transcript in 
central mucoepidermoid carcinoma of 
mandible—diagnostic and histogenetic 
implications
Bell D, et al25 Ann Diagn Pathol 2010 USA
For the first time the t (11; 19) 
fusion transcript was identified 
in an IMEC
7
Cytokeratin expression in central 
mucoepidermoid carcinoma and 
glandular odontogenic cyst
Pires FR, et al.4 Oral Oncol 2004 Brazil
Comparing the CK expression 
(cytokeratins) of GOC and IMEC, 
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Of the articles found, the first one was published in 
2004, the next ones only in 2010 and 2012. Two articles 
were published in 2014, one in 2015, and the last one in 
2017. As for demographic distribution, the United States 
were the ones that published the most, with 71.4%, while 
China and Brazil were similar with 14.3%, according 
to data in Table 2. Six articles used the experimental 
methodology with different numbers of cases and only one 
article analyzed the records, according to Table 3.
The  fac t  tha t  in t raosseous ,  o r  cen t ra l , 
mucoepidermoid carcinoma (IMEC) is a carcinoma with 
glandular characteristics, prevalent in salivary glands, and 
presents, even if rarely, a primary site in a bone region, 
raises several doubts regarding its etiology. Such doubts, 
if clarified, could affect its diagnosis, prognosis, and 
treatment22.
Trying to find such answers, the researchers of the 
selected articles4,14,18,22-25 used at least one of three distinct 
methodologies, in addition to the standard anatomical, 
pathological, and histological analysis with hematoxylin 
and eosin, to identify similar characteristics among possible 
precursors and agents involved in carcinogenesis, namely: 
immunohistochemistry, fluorescent in situ hybridization 
(FISH), and reverse transcriptase polymerase chain reaction 
(RT-PCR).
As it was shown, the selected articles relate to 
each other, sometimes agreeing, sometimes bringing up 
contrary facts that may cast doubt on the theories they 
support about the etiology of IMEC. Thus, organizing 
them in chronological order, as we will do, facilitates the 
perception of these interactions.
In 2004, Pires et al.4, in a study whose objective was 
to evaluate the cytokeratin (CK) profile of central IMEC and 
glandular odontogenic cysts (GOC) to compare the results 
with the expression of CK in MEC of salivary glands, 
odontogenic cysts and tumors, used immunohistochemistry 
to identify CKs found in 23 cases of MECs - parotid 
(10 cases), palate (5 cases), submandibular (4 cases), 
retromolar (4 cases) - and in 46 odontogenic lesions - 10 
dentigerous cysts, 14 keratocysts, 10 periapical cysts, and 
12 ameloblastomas - in order to outline the profile of CKs 
of these lesions, and to establish correlations among them 
and among the 6 IMECs and 10 glandular odontogenic 
cysts (GOC).
The authors say that CKs are a group of intermediate 
filaments expressed mainly by epithelial cells, which 
include a wide range of proteins, varying in molecular 
weight, acidic/basic composition, and affinity4. The 
immunohistochemical expression of CKs has been 
considered a useful tool in the identification of different 
types and epithelial origins. Some studies claim that it is 
possible to establish the origin of a cyst or tumor through 
immunohistochemical expression of CKs. However, this is 
not easily applicable to odontogenic and glandular lesions, 
as the expression of CK varies according to different stages 
of differentiation, from embryonic to adult and specialized 
tissues. GOCs were used in the study because they possibly 
have some relationship with MECs, being a precursor or 
even an initial version of the tumor with less dysplasia, as 
later concluded by Greer et al.4,14.
It was then shown that the excretory ducts of the 
salivary gland can show a broad profile of CK expression, 
including CKs 4, 5, 6, 7, 8, 13, 14, 16, 18, 19, and MECs 
show a similar profile4. All GOCs expressed CKs 5, 7, 8, 
13, 14, 19. All odontogenic cysts expressed CKs 5, 13, 14 
and 91% also expressed CK19. Only 7% of odontogenic 
lesions expressed CK18, which was expressed by all MECs 
and IMECs. In addition, almost 100% of consistency was 
found in the expression of CKs 7, 8, 18 in salivary IMECs 
and MECs, suggesting that IMEC, which presumably 
arises from the odontogenic epithelium, have reached the 
biological nature of salivary MECs. The study also suggests 
that MEC and GOC are distinct entities with different CK 
profiles and that the expression of CKs 18,19 can be useful 
auxiliary tools in the differentiation of these two entities4.
Using RT-PCR, Bell et al.25 were the first to identify 
the CRTC1/MAML2 fusion transcript of the translocation 
of the t (11; 19) genes in IMECs25. When the study was 
conducted, with the aim of analyzing the influence of 
the CRTC1-MAML2 fusion transcript on the prognosis, 
malignancy, and appearance of IMEC, it was  known that 
this chimeric gene could be found in most MECs and 
would play an important role in carcinogenesis, including 
MECs in different locations (bronchiolar, cervix, breast), 
some Warthin’s tumors, and clear cell hydroadenoma of the 
skin, but not in other types of malignancies. Collectively, 
these results indicate a role for the fusion gene as an early 
or etiological event in the development and/or malignant 
transformation of numerous benign and malignant epithelial 
tumors; however, it has not yet been found in IMECs25.
These researchers used RT-PCR looking for the 
fusion transcript in three IMECs. In one of the chosen 
cases, case three, the patient had, in addition to the IMEC, 
a retromolar MEC, also investigated for the presence of 
the chimeric gene. The research was positive in two of 
the three IMEC, including in case three, and negative in 
one IMEC and in the MEC. In this case, both the presence 
and absence of the fusion transcript were critical, as they 
led the researchers to the following conclusions: IMECs 
can display the fusion transcript; in case three, both MEC 
and IMEC were primary tumors due to the expression of 
different genes; the presence of the t (11; 19) fusion gene in 
a subgroup of IMECs, even if speculatively, reinforces the 
idea of tumor development from ectopic salivary tissue, and 
the absence of the t (11; 19) fusion gene in a subgroup of 
IMECs raises the possibility of a different histogenesis of 
the positive transcribed group, stemming from a glandular 
odontogenic precursor25.
Immunohistochemistry was used to analyze 39 
IMECs, in addition to six cases of MECs originating from 
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salivary glands, and eight cases of GOCs for comparative 
studies, aiming to clarify the pathological clinical profile 
and the pathogenesis of IMEC18. Clinicopathological 
findings and follow-up data from 39 cases were collected 
and analyzed. There were 16 male and 23 female patients 
(median age 43 years). Sixteen cases affected the maxilla 
and 23 occurred in the mandible. All central MECs 
expressed CKs 7, 8 and 18, while only 12.5% of GOCs 
stained positively for CK 7, 8 and 18, in agreement with 
the conclusion of the study by Pires et al. 2004, stating 
that they are different lesions and that these markers can 
be useful adjuvants in differentiating IMEC and GOC18.
In cases where there is direct evidence of an 
association with a preexisting odontogenic cyst, the 
hypothesis that mucous metaplasia and neoplastic 
transformation of odontogenic cyst may be the pathogenesis 
of IMEC is supported. The most likely pathogenesis of 
IMEC is the neoplastic transformation of the epithelial 
lining of an odontogenic cyst, the diagnosis of which shall 
be based on clinical, radiographic, and histopathological 
findings18.
In 2014, using FISH (a method that uses molecular 
resources to analyze chromosomes), 23 authors tried 
to identify the chimeric gene MECT1-MAML2 in ten 
odontogenic cysts (ODCs) with prosoplasia for mucous 
cells and in three IMECs. All three IMECs demonstrated 
MAML2 rearrangement in 26%-61% of tumor cells. The 
successful hybridization process was observed in nine of 
the 10 ODCs. In two of these nine, there was MAML2 
rearrangement in 12% and 24% of the lining epithelial cells, 
while three of the nine had rearrangement in 7%-8% of the 
cells; the remaining four cases were negative. MAML2 
rearrangements were identified in five of the nine cases of 
ODCs coated by mucus-secreting cells23.
Based on these findings, two hypotheses were 
elaborated: (1) a subset of ODCs can harbor the MAML2 
rearrangement in the epithelial lining and can be 
transformed into IMEC without obvious phenotypic 
changes or (2) ODCs with MAML2 rearrangement would 
be better considered cystic IMECs. It is plausible that the 
gradual increase in genomic instability in the epithelial 
lining of ODCs through additional rearrangements of 
MAML2 or changes in several tumor suppressor genes, 
such as DCC, SMAD4, GALR1 and CDKN2A/B, can lead 
to malignant transformation and acquisition of the MEC 
phenotype, although these results shall be confirmed by 
additional large-scale studies including the investigation 
of other genes, such as DCC, SMAD4, GALR1 and 
CDKN2A/B23.
Some researchers seeking to clarify the relationship 
between GOC and central MEC performed molecular 
analysis of MAML2 by FISH method on 5 IMECs and 21 
GOCs24. The rearrangement of MAML2 was identified in 
all five cases of central MEC. Alternatively, all 21 GOCs 
were negative for MAML2 rearrangement (100 vs. 0%; 
p \ 0.0001, Fisher’s exact). In addition, in IMECs, the 
rearrangement of MAML2 was evenly distributed among 
the solid, invasive, and coating components.
The coating component is morphologically 
similar to a GOC and, based on this similarity, GOC was 
incriminated by some as a precursor from which the central 
MECs arise. GOC does not appear to represent an early or 
low-grade form of IMEC, but an unrelated lesion. The high 
sensitivity and specificity of the MAML2 rearrangement for 
MECs points to its usefulness as a diagnostic adjuvant in 
the separation of cystic mucinous lesions of gnathic bones.
Therefore, they conclude that the impressive 
disparity in MAML2 status suggests that GOC and central 
MEC are separate entities, and that GOC should not be 
considered an initial or low-grade form of MEC, not even 
a precursor to MEC, which is in agreement with the results 
of Pires et al.4, Zhou et al.18 and Bishop et al.24.
In 2015, researchers returned to the topic, but this 
time with a retrospective analysis of the records of 25 cases 
of IMECs where RT-PCR and FISH were used to search 
for the t (11; 19) fusion gene, whose fusion transcript is 
the chimeric CRTC1 gene -MAML222.
In two of these cases, the tumors were reclassified 
as odontogenic carcinoma and adenosquamous carcinoma, 
although the initial biopsy of both was indicative of 
mucoepidermoid carcinoma. Nine tumors contained 
CRTC1-MAML2 fusion transcript and seven tumors were 
negative for fusion transcription; the status of the remaining 
7 tumors was not available. Of the 7 tumors negative for 
fusion, 4 were radiographically associated with cysts22.
Such results led researchers to believe that tumors, 
where it is possible to identify the t (11; 19) translocation 
fusion gene, originate from ectopic remains of salivary 
glands and that its absence denotes an origin from a 
glandular odontogenic precursor. The study concludes 
by stating that primary intraosseous mucoepidermoid 
carcinomas are extremely rare tumors, usually of low grade 
and of a less aggressive nature. The clinical significance of 
malignant tumors resulting from odontogenic or de novo 
cysts should never be underestimated22.
Finally, in 2017, FISH technique was used to 
analyze eleven cases of aggressive and recurrent GOCs in 
search of the MAML2 fusion transcript, evaluating a group 
of biologically aggressive recurrent GOCs (odontogenic 
cysts) to determine whether any case demonstrated unique 
histological characteristics or Mentor-like rearrangements 
(MAML2) common to IMEC14.
  Of the eleven cases, ten molecular studies were 
negative for the presence of the MAML2 fusion transcript 
and one case was positive14. This finding led the researchers 
to conclude that, although very rarely, it is possible for a 
GOC to originate an IMEC, contrary to Bishop et al.24, 
Pires, et al.4 and Zhou et al.18. However, new and broader 
studies have to be conducted.
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CONCLUSION
 
The results of this work, supported by studies through 
the various methodologies presented, point to two main 
etiological hypotheses of intraosseous mucoepidermoid 
carcinoma: (1) derived from an odontogenic cyst and (2) 
derived from ectopic remains.
The evidence from the studies analyzed shows 
that the pluripotent potential of cells contained in 
odontogenic cysts would be responsible for metaplasia and 
subsequent carcinogenesis. The indications that a glandular 
odontogenic cyst could be a precursor find much more 
evidence against it; however, the discovery of a GOC with 
the MAML2 gene leads to the need for further investigation.
In cases derived from ectopic remains, the 
association with t (11; 19) translocation and the CTRC1-
MAML2 fusion transcript as an early or etiological event 
is clear and its study, in addition to tumor differentiation, 
could result in new therapies.
However, due to its rarity, in absolute numbers, 
research on the origin of IMEC is scarce. Additional 
research on carcinogenesis through odontogenic cysts is 
required, as well as additional research on the MAML2 
transcript and the relationship between GOC and IMEC.
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